Techne Corp. Company Profile (NASDAQ:TECH)

About Techne Corp.

Techne Corp. logoBio-Techne Corporation (Bio-Techne), formerly Techne Corporation, develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products around the world. The Company has three business segments: the Biotechnology, Clinical Controls and Protein Platforms divisions. The Biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products around the world. The Clinical Controls segment develops and manufactures controls and calibrators for the global clinical market. The Protein Platforms segment develops and commercializes systems and consumables for protein analysis. Bio-Techne is engaged in providing specialized proteins, including cytokines and growth factors, antibodies, related immunoassays, biologically active small molecules, and other reagents to the research, diagnostics and clinical controls markets.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: TECH
  • CUSIP: 87837710
Key Metrics:
  • Previous Close: $101.19
  • 50 Day Moving Average: $107.39
  • 200 Day Moving Average: $106.89
  • 52-Week Range: $79.95 - $117.42
  • Trailing P/E Ratio: 36.16
  • Foreward P/E Ratio: 26.91
  • P/E Growth: 2.33
  • Market Cap: $3.78B
  • Outstanding Shares: 37,296,000
  • Beta: 0.59
  • Net Margins: 20.94%
  • Return on Equity: 14.49%
  • Return on Assets: 11.00%
  • Debt-to-Equity Ratio: 0.10%
  • Current Ratio: 4.69%
  • Quick Ratio: 3.63%
Additional Links:
Companies Related to Techne Corp.:

Analyst Ratings

Consensus Ratings for Techne Corp. (NASDAQ:TECH) (?)
Ratings Breakdown: 2 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $112.25 (10.93% upside)

Analysts' Ratings History for Techne Corp. (NASDAQ:TECH)
DateFirmActionRatingPrice TargetDetails
8/18/2016Robert W. BairdBoost Price TargetOutperform$115.00 -> $116.00View Rating Details
7/10/2016Leerink SwannReiterated RatingHoldView Rating Details
5/3/2016Janney Montgomery ScottUpgradeNeutral -> Buy$100.00 -> $118.00View Rating Details
11/2/2015Craig HallumLower Price TargetBuy$125.00 -> $110.00View Rating Details
10/29/2015StephensDowngradeOverweight -> Equal WeightView Rating Details
(Data available from 10/28/2014 forward)


Earnings History for Techne Corp. (NASDAQ:TECH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2016Q117$0.79$127.47 millionN/AView Earnings Details
8/17/2016Q416$0.96$0.92$129.23 million$134.80 millionViewListenView Earnings Details
5/3/2016Q316$0.89$1.01$122.65 million$131.00 millionViewN/AView Earnings Details
2/2/2016Q216$0.82$0.88$118.59 million$120.90 millionViewN/AView Earnings Details
10/28/2015Q1$0.85$0.79$116.91 million$12.40 millionViewListenView Earnings Details
8/6/2015Q415$0.86$0.87$116.85 million$117.70 millionViewN/AView Earnings Details
5/5/2015Q315$0.91$0.86$119.30 million$114.20 millionViewN/AView Earnings Details
2/3/2015Q215$0.86$0.89$112.73 million$111.90 millionViewN/AView Earnings Details
10/28/2014Q115$0.87$0.85$108.65 million$108.50 millionViewN/AView Earnings Details
8/11/2014Q414$0.85$0.88$91.80 million$92.50 millionViewN/AView Earnings Details
4/28/2014Q314$0.89$0.94$92.50 million$95.60 millionViewN/AView Earnings Details
2/4/2014Q214$0.80$0.75$84.79 million$84.00 millionViewN/AView Earnings Details
10/29/2013Q114$0.80$0.83$82.36 million$85.70 millionViewN/AView Earnings Details
8/6/2013Q4 2013$0.83$0.82$79.71 million$79.50 millionViewN/AView Earnings Details
4/30/2013Q3 2013$0.90$0.88$84.00 million$81.00 millionViewN/AView Earnings Details
2/5/2013Q2 2013$0.77$0.74$76.40 million$75.10 millionViewN/AView Earnings Details
10/23/2012$0.79$0.75ViewN/AView Earnings Details
7/31/2012$0.85$0.80ViewN/AView Earnings Details
5/1/2012$0.89$0.90ViewN/AView Earnings Details
1/31/2012$0.79$0.76ViewN/AView Earnings Details
10/25/2011$0.84$0.81ViewN/AView Earnings Details
8/2/2011$0.76$0.76ViewN/AView Earnings Details
5/3/2011$0.80$0.84ViewN/AView Earnings Details
2/1/2011$0.68$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Techne Corp. (NASDAQ:TECH)
Current Year EPS Consensus Estimate: $3.47 EPS
Next Year EPS Consensus Estimate: $3.76 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.86$0.92$0.90
Q2 20163$0.88$0.94$0.92
Q3 20161$0.82$0.82$0.82
Q4 20163$0.85$0.93$0.89
Q1 20173$0.76$0.81$0.78
Q2 20173$0.81$0.88$0.85
Q3 20173$0.93$1.00$0.96
Q4 20173$0.93$0.98$0.96
(Data provided by Zacks Investment Research)


Current Dividend Information for Techne Corp. (NASDAQ:TECH)
Annual Dividend:$1.28
Dividend Yield:1.26%
Payout Ratio:45.71% (Based on Trailing 12 Months of Earnings)
36.89% (Based on Current Year Consensus EPS Estimate)
34.04% (Based on Next Year Consensus EPS Estimate)

Dividend History for Techne Corp. (NASDAQ:TECH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Techne Corp. (NASDAQ:TECH)
Insider Ownership Percentage: 2.70%
Institutional Ownership Percentage: 98.19%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/21/2016Roger C LucasDirectorSell100$108.91$10,891.00View SEC Filing  
9/8/2016John L HigginsDirectorSell1,700$109.83$186,711.00View SEC Filing  
9/8/2016Kevin S. GouldSVPSell524$110.50$57,902.00View SEC Filing  
9/2/2016Robert V BaumgartnerDirectorSell6,467$107.17$693,068.39View SEC Filing  
8/24/2016Robert V BaumgartnerDirectorSell3,533$107.10$378,384.30View SEC Filing  
8/17/2016Roger C. LucasDirectorSell100$113.70$11,370.00View SEC Filing  
7/20/2016Roger C LucasDirectorSell100$111.03$11,103.00View SEC Filing  
6/15/2016Roger C LucasDirectorSell100$112.15$11,215.00View SEC Filing  
5/18/2016Roger C LucasDirectorSell100$102.53$10,253.00View SEC Filing  
5/9/2016Charles A DinarelloDirectorSell5,000$101.91$509,550.00View SEC Filing  
5/6/2016Roger C LucasDirectorSell500$100.24$50,120.00View SEC Filing  
4/20/2016Roger C LucasDirectorSell100$92.40$9,240.00View SEC Filing  
3/16/2016Roger C LucasDirectorSell100$92.90$9,290.00View SEC Filing  
2/5/2016Roger C. LucasDirectorSell5,000$83.68$418,400.00View SEC Filing  
8/13/2015Roger C LucasDirectorSell5,000$106.01$530,050.00View SEC Filing  
6/8/2015Randolph C SteerDirectorSell1,000$99.39$99,390.00View SEC Filing  
2/19/2015Howard V OconnellDirectorSell5,000$95.78$478,900.00View SEC Filing  
12/10/2014Karen A HolbrookDirectorSell1,000$92.40$92,400.00View SEC Filing  
12/9/2014Kevin J ReaganVPSell3,591$89.35$320,855.85View SEC Filing  
12/8/2014Charles A DinarelloDirectorSell3,000$90.44$271,320.00View SEC Filing  
8/14/2014Karen A HolbrookDirectorSell5,000$95.54$477,700.00View SEC Filing  
5/7/2014Howard OconnellDirectorSell5,000$91.00$455,000.00View SEC Filing  
3/4/2014Karen HolbrookDirectorSell5,000$89.83$449,150.00View SEC Filing  
2/27/2014Randolph SteerDirectorSell5,000$88.78$443,900.00View SEC Filing  
11/13/2013Randolph SteerDirectorSell15,000$86.20$1,293,000.00View SEC Filing  
11/8/2013Robert BaumgartnerDirectorSell10,000$87.00$870,000.00View SEC Filing  
11/4/2013Roger C LucasDirectorSell10,000$87.64$876,400.00View SEC Filing  
5/6/2013Howard V OconnellDirectorBuy2,361$65.00$153,465.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Techne Corp. (NASDAQ:TECH)
DateHeadline logoBio-Techne Breaks Below 200-Day Moving Average - Notable for TECH (NASDAQ:TECH) - October 26 at 7:38 PM
News IconBio-Techne To Host Conference Call On ... (NASDAQ:TECH) - October 17 at 7:28 PM logoEPS Target Range For Bio-Techne Corp (NASDAQ:TECH) At $3.41 – $3.53 (NASDAQ:TECH) - October 17 at 7:28 PM logoBio-Techne To Host Conference Call On October 31, 2016 To Announce First Quarter Financial Results (NASDAQ:TECH) - October 17 at 7:28 PM
News IconUpdate on Bio-Techne Corp. (NASDAQ:TECH) for the day (NASDAQ:TECH) - October 16 at 10:28 AM logoStem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021 (NASDAQ:TECH) - October 14 at 10:57 AM logoBIO TECHNE : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K/A) (NASDAQ:TECH) - October 14 at 10:56 AM logoBio-Techne Corp (NASDAQ:TECH) Deferred Tax Assets At $0 (NASDAQ:TECH) - October 14 at 10:56 AM logoBIO-TECHNE CORP Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements and Ex (NASDAQ:TECH) - October 14 at 10:56 AM logo$1.36 Billion Stem Cell Assay Market by Type, Kit, Product, Application & End Users - Forecasts to 2021 - Research and Markets (NASDAQ:TECH) - October 13 at 11:35 AM logoBio-Techne Corp. breached its 50 day moving average in a Bearish Manner : TECH-US : October 12, 2016 (NASDAQ:TECH) - October 12 at 9:03 AM logoBio-Techne Corp (NASDAQ:TECH) Mean Rating At $1 (NASDAQ:TECH) - October 8 at 6:59 PM logoStem Cell Assay Market Worth 1,363.3 Million USD by 2021 (NASDAQ:TECH) - October 7 at 7:18 PM logoBio-Techne Corp (NASDAQ:TECH) Accounts Payable At $20.653 Millions (NASDAQ:TECH) - October 6 at 7:23 PM logoBio-Techne Corp (NASDAQ:TECH) EPS Projection For FY2016 At $3.46 (NASDAQ:TECH) - September 29 at 7:31 PM logoACD Launches BaseScope™ Suite of Tissue Analysis Assays Enabling Breakthrough Advances in Molecular Pathology (NASDAQ:TECH) - September 28 at 7:23 PM logoBio-Techne Corp (NASDAQ:TECH) Mean Price Target At $124.666 (NASDAQ:TECH) - September 27 at 7:33 PM logoBio-Techne Corp. breached its 50 day moving average in a Bearish Manner : TECH-US : September 26, 2016 (NASDAQ:TECH) - September 26 at 11:34 AM logoBio-Techne Corp (NASDAQ:TECH)’s Accounts Payable Is $20.653 (NASDAQ:TECH) - September 22 at 7:16 PM logoResearch Analysts Set Bio-Techne Corp (NASDAQ:TECH)’s Price Target At $124.666 (NASDAQ:TECH) - September 17 at 7:01 PM logoForm 4 BIO-TECHNE Corp For: Sep 08 Filed by: HIGGINS JOHN L (NASDAQ:TECH) - September 13 at 10:35 AM logoBio-Techne Corp (NASDAQ:TECH) Mean Price Target Is $124.666 (NASDAQ:TECH) - September 12 at 7:07 PM logoBio-Techne Corp. breached its 50 day moving average in a Bullish Manner : TECH-US : September 9, 2016 (NASDAQ:TECH) - September 9 at 9:59 AM logoETF’s with exposure to Bio-Techne Corp. : September 6, 2016 (NASDAQ:TECH) - September 6 at 7:44 PM logoPrice Target For Bio-Techne Corp (NASDAQ:TECH) Set At $124.666 By Research Analysts (NASDAQ:TECH) - September 3 at 6:42 PM logoBIO-TECHNE CORP Financials (NASDAQ:TECH) - September 2 at 7:32 PM logoBio-Techne Corp. : TECH-US: Dividend Analysis : August 29th, 2016 (record date) : By the numbers : September 1, 2016 (NASDAQ:TECH) - September 1 at 7:37 PM logoBio Techne : Announces Investor Day And Webcast (NASDAQ:TECH) - September 1 at 10:51 AM logoBio-Techne Announces Investor Day And Webcast (NASDAQ:TECH) - August 31 at 10:38 AM logoBio-Techne Corp. :TECH-US: Earnings Analysis: 2016 By the Numbers : August 30, 2016 (NASDAQ:TECH) - August 30 at 10:59 AM logoBIO-TECHNE CORP Files SEC form 10-K, Annual Report (NASDAQ:TECH) - August 29 at 7:37 PM logoForm 4 BIO-TECHNE Corp For: Aug 24 Filed by: BAUMGARTNER ROBERT V (NASDAQ:TECH) - August 27 at 6:50 PM logoBio-Techne Corp (TECH) Ex-Dividend Date Scheduled for... (NASDAQ:TECH) - August 24 at 10:47 AM logoEx-Dividend Reminder: Nordstrom, Great Plains Energy and Bio-Techne (NASDAQ:TECH) - August 23 at 12:15 PM logoETF’s with exposure to Bio-Techne Corp. : August 22, 2016 (NASDAQ:TECH) - August 22 at 7:38 PM logoAnalysts Set $124.666 Price Target For Bio-Techne Corp (NASDAQ:TECH) (NASDAQ:TECH) - August 22 at 10:38 AM logoBio-Techne Corp. :TECH-US: Earnings Analysis: Q4, 2016 By the Numbers : August 19, 2016 (NASDAQ:TECH) - August 19 at 10:42 AM logoEdited Transcript of TECH earnings conference call or presentation 17-Aug-16 1:00pm GMT (NASDAQ:TECH) - August 18 at 10:48 AM logoBIO-TECHNE CORP : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:TECH) - August 17 at 8:03 PM logoBIO-TECHNE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements (NASDAQ:TECH) - August 17 at 8:03 PM logoBRIEF-Bio-Techne posts Q4 adjusted EPS of $0.92 (NASDAQ:TECH) - August 17 at 10:42 AM logoBIO TECHNE : Techne misses 4Q profit forecasts (NASDAQ:TECH) - August 17 at 10:42 AM logoTechne misses 4Q profit forecasts (NASDAQ:TECH) - August 17 at 10:42 AM logoBio-Techne Corp. Q4 Earnings Rise 3% (NASDAQ:TECH) - August 17 at 10:42 AM logoQ4 2016 Bio-Techne Corp Earnings Release - Before Market Open (NASDAQ:TECH) - August 17 at 10:42 AM logoBio-Techne Declares Dividend (NASDAQ:TECH) - August 17 at 10:42 AM logoBio-Techne Releases Fourth Quarter Fiscal 2016 Results (NASDAQ:TECH) - August 17 at 10:42 AM logoGlycobiology Market: Global Industry Analysis and Forecast 2016-2024 (NASDAQ:TECH) - August 16 at 7:49 PM logoMedical Stocks' Earnings to Watch Next Week: TECH, WVE, EARS (NASDAQ:TECH) - August 12 at 10:59 AM logoPRA Health Sciences Vs. Medpace: How 2 Medical IPOs Stack Up (NASDAQ:TECH) - August 11 at 11:07 AM


Techne Corp. (NASDAQ:TECH) Chart for Friday, October, 28, 2016

Last Updated on 10/28/2016 by Staff